SCYX: the cash flow

MyFinsight

For the year ending 2025-12-31, SCYX had $4,853K increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net (loss) income	-8,609
Stock-based compensation expense	2,852
Accretion of investment discount	474
Amortization of debt issuance costs and discount	312
Change in fair value of warrant liabilities	-5,773
Change in fair value of derivative liability	0
Noncash operating lease expense for right-of-use asset	326
Prepaid expenses and other current assets, deferred costs, and other	-2,166
License agreement contract asset	-9,509
License agreement receivable	-753
Accounts payable	-2,234
Accrued expenses	-1,002
Deferred revenue	-2,702
Other liabilities and other	-407
Net cash used in operating activities	-5,283
Purchase of investments	18,903
Maturity of investments	43,209
Net cash provided by investing activities	24,306
Proceeds from common stock issued	5
Payment of convertible debt	14,000
Payments of deferred offering costs	226
Proceeds from employee stock purchase plan issuances	51
Net cash used in financing activities	-14,170
Net increase (decrease) in cash, cash equivalents, and restricted cash	4,853
Cash, cash equivalents, and restricted cash at beginning of period	16,595
Cash, cash equivalents, and restricted cash at end of period	21,448

Unit: Thousand (K) dollars (except for numbers of shares and EPS).